MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug ...

Adia Med, a division of ADIA Nutrition Inc. (OTC Pink: ADIA), is driving a transformative effort to standardize umbilical ...

A bacterium makes a molecule that kills drug-resistant fungi in an unusual way — by targeting various phospholipid molecules ...

Tumor inflitrating lymphocyte therapies are a promising type of cellular immunotherapy used to treat a broad range of solid malignant tumors.

Proprietary platform represents the first known approach capable of sustained γδ T cell expansion, eliminating target cells with robust potency; INB-619, a next generation γδ ...

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce ...

PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing 48% growth over Q3 2024 net product revenue of $9.3 ...

Immuno-oncology and cell-based treatments, which harness the body's own immune system to combat illnesses like cancer, have emerged as some of the most promising areas of study. This article explores ...

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce ...

Interestingly, this approach results in higher-quality T-cells, with enhanced potency and better persistence in the blood while avoiding excess toxicity. These improvements could make CAR T-cell ...

is associated with differences in these cells' levels of FLI-1 activity, affecting their potency to interact with a regenerative vascular niche. The study involved extensive computational analysis to ...